Effect of thyrotropin suppressive therapy on heart rate variability and QT dispersion in patients with differentiated thyroid cancer
Authors:
- Haihong LvHLHaihong Lv
- Qian LiQLQian Li
- Songbo FuSFSongbo Fu
- Jiaojiao TanJTJiaojiao Tan
- Chenyi WangCWChenyi Wang
- Xiaoqian WangXWXiaoqian Wang
- Yuping MaYMYuping Ma
Open Access
- 10 July 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (28) , e21190
Abstract
The effects of thyrotropin (TSH) suppressive therapy on autonomic regulation and ventricular repolarization in patients with differentiated thyroid cancer (DTC) have not been elucidated. The aim of present study was to evaluate variation in heart rate variability (HRV) and QT dispersion after TSH suppressive therapy in patients with DTC. Cases, defined as 271 patients with DTC within 1 year of exogenous levothyroxine, and all patients underwent a full history, physical examination, including standard 12 lead electrocardiogram (ECG), and 24 h ambulatory ECG monitoring (Holter) with normal free thyroxine (FT4) and free triiodothyronine (FT3) with levothyroxine. To evaluate effects of TSH suppressive therapy on HRV and QT dispersion, patients were divided into three groups according to different levels of TSH: TSH < 0.1 mIU/L group and 0.1 ≤ TSH < 0.5 mIU/L group were as TSH suppression groups, and 0.5 ≤ TSH < 2.0 mIU/L group was as TSH replacement group. Comparing with 0.5 ≤ TSH < 2.0 mIU/L group, significant changes in both time and frequency domain of HRV and QT dispersion were observed in TSH < 0.1 mIU/L group (P < .001: SDNN, SDANN, HF, LF/HF, QTd, and QTcd; P < .05: rMSSD) and 0.1 ≤ TSH < 0.5 mIU/L group (P < .001: SDNN, HF, LF/HF, QTd, and QTcd), and especially were more pronounced in TSH < 0.1 mIU/L group. Moreover, we found that TSH level was proportional to SDNN (β = 15.829, P < .001), but inversely proportional to LF/HF (β = −0.671, P < .001), QTd (β = −16.674, P < .001) and QTcd (β = −18.314, P < .001) in DTC patients with exogenous levothyroxine. Compared with euthyroid state, patients with suppressed serum TSH have increased sympathetic activity in the presence of diminished vagal tone, ultimately showed sympathovagal imbalance and with an increased inhomogeneity of ventricular recovery times. These findings revealed that TSH suppression therapy had a significant impact on cardiovascular system and had certain guiding role in the treatment and management of patients with DTC.Keywords
Funding Information
- Gansu scientific research projects in health Grant (No. GSWSKY2018-47.)
This publication has 30 references indexed in Scilit:
- The Influence of Subclinical Hyperthyroidism on Blood Pressure, Heart Rate Variability, and Prevalence of ArrhythmiasThyroid®, 2012
- Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic riskBritish Journal of Pharmacology, 2011
- Short‐term overt hypothyroidism induces sympathovagal imbalance in thyroidectomized differentiated thyroid carcinoma patientsClinical Endocrinology, 2010
- Higher Serum Thyroid Stimulating Hormone Level in Thyroid Nodule Patients Is Associated with Greater Risks of Differentiated Thyroid Cancer and Advanced Tumor StageThe Journal of Clinical Endocrinology & Metabolism, 2008
- Prolonged Ventricular Repolarization Measured by Corrected QT Interval (QTc) in Subclinical HyperthyroidismHormone and Metabolic Research, 2006
- Electrophysiologic Characteristics of Atrial Myocytes in Levo-thyroxine-Treated RatsThyroid®, 2005
- Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancerAnnals of Medicine, 2002
- Determinants of heart rate variabilityJACC, 1996
- Heart rate variability: A measure of cardiac autonomic toneAmerican Heart Journal, 1994
- Effect of thyroid state on cytosolic free calcium in resting and electrically stimulated cardiac myocytesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1988